证券简称：锦盛新材 证券代码：300849 浙江锦盛新材料股份有限公司投资者关系活动记录表 编号：2021-003 | --- | --- | --- | --- | --- | |-----------------------------|-------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|-------------|--------------| | | | | | | | | | 特定对象调研 □分析师会议 | | | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | | | 类别 | □新闻发布会 □路演活动 | | | | | | | □现场参观□其他（请文字说明其他活动内容） | | | | 参与单位名称 及人员姓名 | ...

证券简称：锦盛新材 证券代码：300849 浙江锦盛新材料股份有限公司投资者关系活动记录表 编号：2021-002 | --- | --- | --- | |-------------------------|----------------------------------|-----------------------------------------------------------------------| | | | | | | □媒体采访 | 特定对象调研 □分析师会议 □业绩说明会 | | 投资者关系活动 类别 | | □新闻发布会 □路演活动 | | | | □现场参观□其他（请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | Evli Group ： | Burton Flynn& Ivan Nechunaev | | 时间 | 2021 年 11 月 2 | 日（星期二）下午 15:00-16:00 | | 地点 | 公司三楼会议室（视频会议） | | | 上市公司接待人员 姓名 | 董事长：阮荣涛 IT 总监：阮岑泓 | 董事会秘书兼财务总监：段刘滨 子公司上海健弘科技 ...

Financial Performance - The company's revenue for Q3 2022 was ¥46,537,412.18, a decrease of 34.99% compared to the same period last year[5] - The net profit attributable to shareholders was -¥6,875,861.97, reflecting a decline of 404.13% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥6,845,809.14, down 630.37% from the previous year[5] - The company reported a revenue of 186.03 million RMB for the first nine months of 2022, a decrease of 13.15% compared to the same period in 2021[9] - The net profit attributable to shareholders was -4.17 million RMB, representing a decline of 127.49% year-on-year[10] - The gross profit margin for the first nine months of 2022 was 10.59%, down 15.00% from 25.59% in the same period last year[10] - Total operating revenue for the third quarter of 2022 was CNY 186,027,437.78, a decrease of 13.16% compared to CNY 214,184,103.62 in the same period last year[16] - The net profit for the third quarter of 2022 was a loss of CNY 4,173,276.61, compared to a profit of CNY 15,183,095.22 in the previous year, indicating a significant decline[18] - The total comprehensive income for the third quarter was -4,173,276.61 CNY, compared to 15,183,095.22 CNY in the previous period[19] - Basic and diluted earnings per share were both -0.0278 CNY, down from 0.1012 CNY in the previous period[19] Cash Flow and Investments - The operating cash flow net amount for the year-to-date was ¥46,293,140.41, an increase of 364.49%[5] - The net cash flow from operating activities increased by 364.49% to 46.29 million RMB, attributed to increased government subsidies and improved receivables collection[9] - Investment activities generated a net cash flow of -101.32 million RMB, a decrease of 897.29% compared to the previous year, due to reduced idle funds and ongoing project investments[9] - Cash inflow from investment activities totaled 99,640,292.79 CNY, down from 380,480,487.02 CNY in the previous period[20] - Cash outflow from investment activities was 200,959,171.19 CNY, compared to 367,772,564.76 CNY in the previous period[20] - Net cash flow from financing activities was 10,539,506.67 CNY, a recovery from -9,171,962.00 CNY in the previous period[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥773,640,031.94, a decrease of 0.41% from the end of the previous year[5] - Current assets decreased to CNY 346,239,675.02 from CNY 421,023,755.23, representing a decline of 17.74%[14] - Non-current assets increased to CNY 427,400,356.92 from CNY 355,829,751.09, showing a growth of 20.06%[14] - The total liabilities as of September 30, 2022, were CNY 110,027,209.86, up from CNY 94,067,407.63, marking an increase of 16.96%[15] - The owner's equity attributable to shareholders decreased by 2.81% to ¥663,612,822.08 compared to the end of the previous year[5] Shareholder Information - The company had a total of 9,475 common shareholders at the end of the reporting period[11] - The largest shareholder, Ruan Rongtao, holds 20.32% of the shares, while the top ten shareholders collectively control 35.11% of the company[11] Operational Challenges - The company faced challenges in order volume and capacity utilization due to domestic and international pandemic impacts and macroeconomic factors[10] Other Financial Metrics - Financial expenses decreased by 22,771.10% to -13.55 million RMB, primarily due to foreign exchange gains from the rising USD exchange rate[9] - The company experienced a significant increase in other expenses, with non-operating expenditures rising by 866.86% to 830.35 thousand RMB, mainly due to asset scrapping and increased donations[9] - The tax and additional fees increased by 3747.09% to ¥757,262.73, due to a significant increase in the base for tax calculation compared to the previous year[8] - The company reported a significant increase in construction in progress, rising by 731.68% to ¥86,093,438.74, attributed to the "annual production of 60 million cosmetic packaging containers" project[8] - The short-term borrowings increased by 61.29% to ¥71,059,021.00, primarily due to new bank loans[8]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥139,490,025.60, a decrease of 2.18% compared to ¥142,599,797.87 in the same period last year[22]. - The net profit attributable to shareholders for the first half of 2022 was ¥2,702,585.36, representing a significant decline of 79.09% from ¥12,922,253.36 in the previous year[22]. - The basic earnings per share decreased by 77.78% to ¥0.02, down from ¥0.09 in the previous year[22]. - The company reported a net profit after deducting non-recurring gains and losses of -¥2,608,913.54, a decline of 140.26% from ¥6,480,508.62 in the previous year[22]. - The total profit for the first half of 2022 was ¥4.09 million, a decline of 72.6% from ¥14.89 million in the same period of 2021[181]. - The total comprehensive income for the first half of 2022 was ¥4.48 million, down 66.9% from ¥13.52 million in the same period of 2021[182]. - The company's gross profit margins have fluctuated significantly, recorded at 36.07%, 23.27%, and 14.55% over the past two years and the first half of 2022, indicating potential risks from raw material price volatility[99]. Cash Flow and Investments - The net cash flow from operating activities increased by 104.78% to ¥20,758,701.57, compared to ¥10,137,149.26 in the same period last year[22]. - The company reported a fair value change profit amounted to 1,148,403.77, accounting for 51.59% of total profit, primarily due to the investment in financial products using idle funds[74]. - The company reported a net cash flow from investment activities was negative at CNY -36,181,090.31, a decline from a positive CNY 24,740,657.34 in the first half of 2021[185]. - Cash inflow from investment activities decreased to CNY 99,906,541.13, down 66.8% from CNY 300,568,892.58 in the previous year[185]. - The company has invested a total of RMB 29,285 million in committed investment projects, with cumulative investments reaching RMB 27,543.25 million, achieving a progress rate of 94.05%[88]. Market and Sales Performance - Domestic sales decreased by 4.93 million yuan, while foreign sales increased by 1.82 million yuan[31]. - The decline in performance was primarily due to the impact of domestic and international pandemic situations and changes in consumer behavior[31]. - The company has established stable, long-term partnerships with high-end clients such as Estée Lauder and L'Oréal, enhancing its market position[62]. - The company's export sales to the U.S. accounted for 38.85%, 29.20%, and 29.75% of total revenue in the past two years and the first half of 2022, highlighting the impact of U.S.-China trade tensions on its business[105]. - The company is positioned to benefit from the growing international demand for cosmetic packaging, leveraging its geographical advantages and established supply chains[58]. Research and Development - Research and development expenses rose by 9.68% to ¥7,235,111.88 from ¥6,596,858.27, reflecting the company's commitment to enhancing competitiveness through new product development[68]. - The company is committed to enhancing R&D capabilities and increasing investment in new product development to improve gross margins and maintain competitive advantages[99]. - The company holds 64 patents, demonstrating strong research and development capabilities in precision cosmetic plastic bottle mold development[61]. Operational Challenges - The fluctuation in raw material prices, particularly plastics like PMMA, PETG, ABS, AS, and PP, poses a risk to the company's operating capital and production costs due to volatility influenced by oil prices and trade policies[106]. - The COVID-19 pandemic has severely impacted global logistics and business activities, with the company's export revenue being significantly affected, particularly in Europe and the Americas, leading to delayed shipments and reduced customer orders[107]. - The company has faced challenges in achieving expected benefits from the "Annual Production of 45 million sets of cosmetic packaging container new construction project" due to high fixed costs and underutilization of scale effects[88]. Corporate Governance and Compliance - The company has not reported any significant changes in the measurement attributes of its major assets during the reporting period[79]. - The company has adhered to environmental regulations and has not faced any administrative penalties related to environmental issues during the reporting period[120]. - The company strictly adheres to legal regulations to protect employee rights, ensuring no wage deductions or delays occurred during the reporting period[122]. - The company has not experienced any major litigation or arbitration matters during the reporting period[131]. Future Outlook - The company plans to continue expanding its market presence and invest in new product development[190]. - The company aims to leverage strategic partnerships to enhance its competitive edge in the market[190]. - The company has set a target for revenue growth of approximately 10% for the next fiscal year, driven by new product launches and market expansion strategies[194].

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 浙江锦盛新材料股份有限公司 2022 年第一季度报告全文 证券代码：300849 证券简称：锦盛新材 公告编号：2022-024 浙江锦盛新材料股份有限公司 2022 年第一季度报告 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 66,943,366.32 | 64,581,744.24 | 3.66% | | 归属于上市公司股东的净利润（元） | 2,217,498.29 | 8,173,34 ...

Financial Performance - The net profit attributable to shareholders of the listed company for 2021 was 10.587 million RMB, a decrease of 69.30% compared to 34.4894 million RMB in the same period last year[5]. - The decline in profit was primarily due to rising raw material prices, increased personnel costs, and a decrease in export sales caused by the pandemic and shipping uncertainties[5]. - The company's operating revenue for 2021 was ¥293,159,461.84, representing a 12.94% increase compared to ¥259,561,794.03 in 2020[19]. - The net profit attributable to shareholders decreased by 69.30% to ¥10,586,961.03 in 2021 from ¥34,489,371.21 in 2020[19]. - The net profit after deducting non-recurring gains and losses was ¥2,341,985.69, down 92.33% from ¥30,516,105.29 in the previous year[19]. - The net cash flow from operating activities was ¥28,766,992.00, a decrease of 50.66% compared to ¥58,299,970.87 in 2020[19]. - The total assets at the end of 2021 were ¥776,853,506.32, an increase of 4.84% from ¥740,999,805.53 at the end of 2020[19]. - The net assets attributable to shareholders decreased by 2.07% to ¥682,786,098.69 from ¥697,199,137.66 in 2020[19]. - The basic earnings per share dropped by 74.07% to ¥0.07 in 2021 from ¥0.27 in 2020[19]. - The weighted average return on net assets was 1.53%, down 5.24% from 6.77% in the previous year[19]. - The gross profit margin decreased to 23.14% in 2021 from 35.59% in 2020, a drop of 12.45%[67]. - The gross profit margin for the injection molded parts was 23.27%, down 12.80% compared to the previous year[75]. Research and Development - The company established a wholly-owned subsidiary, Shanghai Jianhong Technology Co., Ltd., in July 2021 to enhance R&D capabilities, which has not yet turned profitable[5]. - The company plans to continuously increase R&D investment to improve product quality and develop new products to enhance market competitiveness[6]. - The company has invested in product design and technology development to enhance its competitiveness against overseas rivals, particularly in product design[35]. - The company has a strong focus on research and development, particularly in acrylic packaging, to maintain its competitive edge in the industry[37]. - The company's R&D investment amounted to ¥14,532,416 in 2021, representing 4.96% of total revenue, an increase from 4.28% in 2020[88]. - The number of R&D personnel increased by 18.82% from 85 in 2020 to 101 in 2021, with a notable rise in the proportion of personnel under 30 years old[88]. - The company is focusing on enhancing customer satisfaction and market competitiveness through various R&D projects aimed at improving product quality and sustainability[86]. - The company plans to enhance its R&D capabilities by collaborating with top research institutions and attracting high-end talent to develop innovative packaging solutions[122]. Market Position and Strategy - The company has established itself as a supplier for well-known cosmetic brands including Estée Lauder, L'Oréal, and Pechoin, indicating a strong market presence[37]. - The company is well-positioned to capitalize on the growing potential of the Chinese cosmetic market, which is attracting international brands[35]. - The company aims to strengthen marketing efforts to develop new high-quality customers and improve overall operational profitability[6]. - The company is focusing on expanding its market share both domestically and internationally, aiming to reduce the impact of global trade conflicts on sales[124]. - The company is actively seeking partnerships to leverage synergies and enhance its product offerings in the new materials sector[154]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[163]. Production and Operations - The company operates under a just-in-time production model, minimizing inventory and ensuring efficient order fulfillment[48]. - The company has developed strong capabilities in mold design and injection technology, which enhances cooperation with high-end clients and supports higher profit margins[54]. - The company has mastered advanced mold processing technologies, including multi-cavity mold technology and high-precision manufacturing techniques[56]. - The company is leveraging intelligent warehousing and logistics systems to improve efficiency and reduce delivery times[121]. - The company has established a new project with an annual production capacity of 45 million cosmetic packaging containers, which was launched in July 2021[69]. - The company plans to extend its product line into color cosmetics and personal care packaging with a new project for 60 million sets of packaging containers, which commenced construction in January 2022[70]. Financial Management and Governance - The company proposed a profit distribution plan to distribute a cash dividend of 1.00 RMB per 10 shares to all shareholders[7]. - The company has established a cash dividend management system and a three-year shareholder return plan for 2021-2023, which has been approved by independent directors[182]. - The company reported a distributable profit of RMB 185,826,307.01 for the year[183]. - The company has a structured governance framework with a shareholders' meeting as the highest authority, a board of directors for decision-making, and a supervisory board for oversight[148]. - The company has established a governance structure that complies with relevant laws and regulations, ensuring transparency and accountability in its operations[140]. - The company emphasizes maintaining the interests of all shareholders, particularly minority investors[171]. Challenges and Risks - The company faced a 25% tariff on $200 billion worth of goods exported to the U.S. since May 2019, directly impacting its export business[133]. - The company experienced delays in shipments and reduced customer orders due to the COVID-19 pandemic, affecting its operational efficiency[135]. - Upstream raw material prices, particularly for PMMA, ABS, AS, significantly impact production costs; in 2021, these materials saw substantial price increases affecting profit levels[53]. - The company is enhancing its R&D capabilities and product competitiveness to mitigate risks from U.S. tariffs and raw material price fluctuations[133][134]. Employee Management - The total number of employees at the end of the reporting period is 920, with 699 in production, 101 in technical roles, and 25 in sales[176]. - Employee compensation policies are designed to be fair and competitive, aligning with local industry standards and rewarding performance through bonuses[177]. - The company emphasizes training across multiple levels, focusing on management, technical, and process-related skills to enhance employee capabilities[179]. - The company has no retired employees requiring financial support, indicating a fully active workforce[176]. Environmental and Social Responsibility - The company strictly adheres to environmental laws and has not faced any administrative penalties related to environmental issues during the reporting period[194]. - The company promotes green manufacturing and aims to eliminate high-energy-consuming and high-polluting production lines[198]. - The company emphasizes employee rights protection, ensuring compliance with labor laws and providing various social insurance benefits[197].

Financial Performance - The company's revenue for Q3 2021 was ¥71,584,305.75, representing a decrease of 5.45% compared to the same period last year[3] - Net profit attributable to shareholders was ¥2,260,841.86, down 73.88% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥1,290,749.60, a decline of 85.46%[3] - Basic and diluted earnings per share were both ¥0.0151, down 82.60% compared to the same period last year[3] - The company achieved operating revenue of RMB 214.18 million for the first three quarters of 2021, an increase of 5.81% compared to the same period last year[9] - Net profit attributable to shareholders was RMB 15.18 million, a decrease of 53.81% year-on-year, primarily due to a decline in gross margin[10] - Gross margin for the first three quarters of 2021 was 25.59%, down 14.18% from 39.77% in the same period last year, mainly due to rising raw material prices and increased labor costs[10] - Net profit for Q3 2021 was CNY 15,183,095.22, a decrease of 53.8% from CNY 32,868,269.30 in Q3 2020[23] - Basic and diluted earnings per share were both CNY 0.1012, down from CNY 0.3287 in the previous year[24] Cash Flow - The cash flow from operating activities for the year-to-date was ¥9,966,417.22, reflecting a significant decrease of 75.10%[3] - The company reported a net cash flow from operating activities of RMB 9.97 million, a decrease of 75.10% compared to RMB 40.03 million in the previous year[9] - Cash inflow from operating activities totaled CNY 235,010,655.84, compared to CNY 208,891,768.59 in the same quarter last year[26] - The net cash flow from operating activities for Q3 2021 was ¥9,966,417.22, a decrease of 75.1% compared to ¥40,030,695.84 in Q3 2020[27] - The total cash inflow from investment activities was ¥380,480,487.02, significantly up from ¥50,152,549.24 in the same period last year[27] - The net cash flow from investment activities was ¥12,707,922.26, recovering from a negative cash flow of ¥332,909,433.73 in Q3 2020[27] - The cash flow from financing activities showed a net outflow of ¥9,171,962.00, compared to a net inflow of ¥284,101,512.94 in Q3 2020[27] Assets and Liabilities - Total assets at the end of Q3 2021 were ¥747,087,021.80, an increase of 0.82% from the end of the previous year[3] - Current assets totaled RMB 398,213,989.39, down from RMB 472,740,887.62 at the end of 2020, indicating a decrease of approximately 15.7%[19] - Inventory increased significantly to RMB 80,922,186.85, compared to RMB 55,633,178.95 at the end of 2020, reflecting a growth of about 45.4%[19] - Fixed assets rose by 41.58% to ¥229,695,484.98, primarily due to the partial acceptance of a new project for cosmetic packaging containers[7] - Total liabilities reached CNY 59,704,788.92, compared to CNY 43,800,667.87 in the previous year[21] - Total equity attributable to shareholders was CNY 687,382,232.88, slightly down from CNY 697,199,137.66 year-on-year[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,422, with the top ten shareholders holding a combined 61.71% of the shares[12] - The company’s major shareholder, Ruan Rongtao, holds 20.32% of the shares, making him the largest shareholder[13] - The company plans to release additional restricted shares on July 10, 2023, totaling 30,486,966 shares held by Ruan Rongtao[15] Other Key Metrics - The company reported a 1673.64% increase in receivables financing to ¥4,631,800.90, mainly due to customers using bank acceptance bills for settlement[7] - The company recorded a 154.53% increase in intangible assets to ¥33,408,659.84, mainly from the purchase of 50 acres of land[7] - Non-recurring gains totaled ¥1,045,262.01 for the current period, with government subsidies contributing significantly to this figure[5] - Research and development expenses increased to CNY 10,510,162.11, up from CNY 8,488,649.81 year-on-year[21] - The company reported a significant increase in sales expenses, which amounted to CNY 5,492,291.90, compared to CNY 7,879,481.77 in the previous year[21] Miscellaneous - The company did not require adjustments to the beginning balance sheet items due to the new leasing standards[29] - The third-quarter report for 2021 was not audited[30] - The company reported a cash flow impact from exchange rate changes of -¥1,028,493.59 in Q3 2021[27]

Financial Performance - The company reported a total revenue of RMB 150 million for the first half of 2021, representing a year-on-year increase of 20% compared to the same period in 2020[15]. - The company's revenue for the reporting period was ¥142,599,797.87, an increase of 12.54% compared to the same period last year[29]. - The company's revenue for the reporting period reached ¥142,599,797.87, representing a year-on-year increase of 12.54% compared to ¥126,713,883.20 in the previous year, primarily due to effective control of domestic COVID-19 and increased domestic sales efforts[66]. - The management has set a revenue target of RMB 300 million for the full year of 2021, representing a 25% growth compared to 2020[15]. - Net profit attributable to shareholders was ¥12,922,253.36, a decrease of 46.63% year-on-year[29]. - Net profit for the first half of 2021 was CNY 12,922,253.36, a decrease of 46.5% from CNY 24,211,898.69 in the first half of 2020[185]. - The net profit after deducting non-recurring gains and losses was ¥6,480,508.62, down 71.62% from the previous year[29]. - The gross profit margin for the first half of 2021 was 35%, which is an improvement from 30% in the first half of 2020[15]. - The gross profit margin for the main business was 27.15%, down from 41.10% in the same period last year, primarily due to rising raw material prices and increased labor costs[30]. - The gross profit margin for injection molded parts decreased by 13.95% to 27.15%[70]. - The company's operating costs rose to ¥104,326,211.95, a significant increase of 39.29% from ¥74,896,723.93 in the previous year, driven by rising raw material prices, increased wages, and higher sales revenue[66]. Research and Development - Research and development expenses increased by 25% year-on-year, totaling RMB 10 million, focusing on new product innovations[15]. - The company has invested in R&D and mold development to continuously create new products for diverse customer needs[31]. - R&D investment rose by 20.54% to CNY 6,596,858.27, aimed at enhancing the company's competitive edge and developing new products[67]. - The company holds 59 patents and has strong R&D capabilities, which have been bolstered by years of technical development and practical experience in precision cosmetic plastic bottle molds[57]. - The company is focusing on expanding its market presence and enhancing its product offerings through increased R&D investment[186]. Market Expansion and Strategy - The company plans to expand its market presence by entering two new regions in 2022, aiming for a 15% increase in market share[15]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[15]. - The company is committed to expanding its market presence and developing new products to reduce reliance on a limited number of core customers[101]. - The company is positioned competitively in the overseas market, benefiting from China's established plastic production base and the growing potential of the domestic cosmetic consumption market[55]. Financial Management and Cash Flow - The company completed a capital increase of RMB 50 million, raising its registered capital to RMB 150 million[21]. - The total amount of raised funds was RMB 349,750,000, with a net amount of RMB 292,850,000 after deducting issuance costs[86]. - The company reported a net increase in cash and cash equivalents of CNY 8,552,606.20, a significant turnaround from a decrease of CNY 1,707,696.14 in the previous period[67]. - The total cash and cash equivalents at the end of the period stood at CNY 143,990,187.83, up from CNY 107,932,528.87 at the end of the first half of 2020, reflecting an increase of approximately 33.4%[194]. - The company received CNY 297,000,000.00 from investment recoveries, indicating a strong performance in investment management[197]. - The net cash flow from operating activities was CNY 10,137,149.26, down from CNY 17,019,388.47 in the first half of 2020, indicating a decline of about 40.5%[193]. - Investment cash inflow reached CNY 300,568,892.58, significantly higher than CNY 8,737.86 in the previous year, marking a substantial increase[194]. Risks and Challenges - The company faces risks related to supply chain disruptions and fluctuating raw material prices, which have been detailed in the risk management section[5]. - The fluctuation of upstream plastic prices significantly impacts production costs, but the industry has managed to control profit levels through efficiency improvements and price adjustments[45]. - The company faced risks from rising labor costs due to economic development in central and western regions, necessitating increased wages to attract workers[103]. - The company is actively monitoring exchange rate fluctuations, as its foreign sales are primarily settled in USD, which poses a risk to its financial performance[105]. Corporate Governance and Compliance - The company held its 2020 annual general meeting with a participation rate of 73.77% on May 27, 2021[113]. - There were no changes in the company's board of directors, supervisors, or senior management during the reporting period[114]. - The company did not implement any employee stock ownership plans or other incentive measures during the reporting period[116]. - The company reported no environmental penalties or violations during the reporting period, adhering to all relevant environmental regulations[119]. - The company emphasized its commitment to social responsibility, ensuring fair treatment of shareholders and employees, and maintaining open communication channels[120]. Shareholder Information - The total number of shares increased from 100,000,000 to 150,000,000, representing a 50% increase due to a capital reserve conversion plan approved by the board[153]. - The largest shareholder, Ruan Rongtao, holds 30,486,966 shares, representing 20.32% of the total shares after an increase of 10,162,322 shares[159]. - The shareholding structure indicates a significant concentration of ownership among the top shareholders, with the top three holding over 45% of the total shares[159]. - The company's stock conversion plan was approved during the board meeting on April 23, 2021, and subsequently ratified by the shareholders on May 27, 2021[154]. Operational Efficiency - The company has developed a complete injection molding technology system, covering various technical aspects such as material feeding, mold matching, and temperature control, enhancing product quality and production efficiency[59]. - The company has implemented automation in injection molding processes, improving production efficiency and reducing labor costs through technologies such as automatic extraction and embedding[58]. - The company has established quality assurance and management departments to ensure that products meet established standards, with rigorous quality control measures in place throughout the production process[62].

Financial Performance - The company's revenue for Q1 2021 was ¥64,581,744.24, representing a 0.95% increase compared to ¥63,975,960.19 in the same period last year[8] - Net profit attributable to shareholders decreased by 37.61% to ¥8,173,345.82 from ¥13,099,961.82 year-on-year[8] - The net profit after deducting non-recurring gains and losses fell by 64.84% to ¥4,386,272.57 compared to ¥12,475,087.59 in the previous year[8] - Basic and diluted earnings per share decreased by 52.94% to ¥0.08 from ¥0.17 year-on-year[8] - The weighted average return on equity was 1.17%, down from 3.48% in the previous year, a decrease of 2.31%[8] - The gross profit margin for Q1 2021 was 28.40%, down 13.73% from 42.13% in the same period last year, primarily due to rising raw material prices and increased labor costs[19] - The company reported a net profit margin decline due to increased operating costs, impacting overall profitability[41] - The net profit for Q1 2021 was CNY 8,173,345.82, down from CNY 13,099,961.82 in the same period last year, representing a decrease of approximately 37.1%[44] - The company reported a total profit of CNY 9,139,393.67 for Q1 2021, down from CNY 15,081,621.28 in the previous year, indicating a decline of approximately 39.4%[44] Cash Flow - The net cash flow from operating activities was negative at -¥3,295,048.31, a decline of 170.72% from ¥4,659,593.60 in the same period last year[8] - Cash flow from operating activities was -3.30 million RMB, a 170.72% decline compared to 46.60 million RMB in Q1 2020[18] - The company's cash and cash equivalents increased to CNY 157,051,519.22 from CNY 135,437,581.63 at the end of 2020, representing a growth of approximately 15%[34] - Cash and cash equivalents at the end of the period totaled 157,051,519.22 CNY, up from 110,301,613.19 CNY in the previous period[51] - The cash flow from financing activities was negative at -65,387.32 CNY, reflecting cash outflows for debt repayment and interest payments[55] Assets and Liabilities - Total assets at the end of the reporting period were ¥744,998,717.17, a slight increase of 0.54% from ¥740,999,805.53 at the end of the previous year[8] - Net assets attributable to shareholders increased by 1.17% to ¥705,372,483.48 from ¥697,199,137.66 at the end of the previous year[8] - The total liabilities decreased to CNY 39,626,233.69 as of March 31, 2021, down from CNY 43,800,667.87 at the end of 2020, a reduction of approximately 9.5%[40] - The total equity attributable to shareholders increased to CNY 705,372,483.48 as of March 31, 2021, compared to CNY 697,199,137.66 at the end of 2020, an increase of about 1.7%[37] Investment Activities - Cash flow from investing activities was 244.72 million RMB, a significant increase from -37.78 million RMB in the same period last year, mainly due to increased investment in fundraising projects[18] - The company has invested a total of CNY 15,994.02 million in fundraising projects, with a project completion rate of 72.87% for the new production line of cosmetic packaging containers[27] - The company plans to increase production capacity by 15 million sets of cosmetic packaging containers annually by 2022[27] - The company reported a 66.08% reduction in credit impairment losses, amounting to -345.50 thousand RMB compared to -1.02 million RMB in Q1 2020[17] Operational Challenges - The company faced risks from exchange rate fluctuations, as foreign sales accounted for 53.44% of total revenue in Q1 2021[21] - The company is addressing rising raw material prices by enhancing product quality and reducing material consumption[22] - Labor cost pressures are being mitigated through technological upgrades and increased automation[23] Research and Development - Research and development expenses for Q1 2021 were CNY 2,842,831.34, slightly up from CNY 2,661,425.45 in Q1 2020, indicating a focus on innovation[41] - Research and development expenses for Q1 2021 were CNY 2,843,874.88, slightly up from CNY 2,661,425.45 in the previous period[46]

Dividend Distribution and Capital Reserves - The company plans to distribute a cash dividend of 2.5 RMB per 10 shares to all shareholders, based on a total of 100,000,000 shares[5]. - The company will also increase capital reserves by converting 5 shares for every 10 shares held by shareholders[5]. - The company plans to distribute a cash dividend of RMB 2.5 per 10 shares, totaling RMB 25,000,000, which represents 100% of the distributable profit[129]. - The total number of shares will increase from 100,000,000 to 150,000,000 due to a capital reserve transfer of 5 shares for every 10 shares held, totaling 50,000,000 new shares[131]. - The company's net profit attributable to ordinary shareholders for 2020 was RMB 34,489,371.21, with a cash dividend payout ratio of 72.49%[134]. - The total distributable profit for the year was RMB 201,595,259.82, with cash dividends accounting for 100% of the total profit distribution[129]. - The company has a policy to ensure that cash dividends represent at least 20% of profit distribution during significant capital expenditure phases[129]. - The cash dividend distribution aligns with the company's articles of association and dividend management policies[129]. - The company has not proposed any cash dividend distribution plans in years when it reported a positive net profit[134]. Financial Performance - The company's operating revenue for 2020 was ¥259,561,794.03, a decrease of 24.30% compared to ¥342,879,253.56 in 2019[15]. - The net profit attributable to shareholders for 2020 was ¥34,489,371.21, down 47.46% from ¥65,641,214.98 in 2019[15]. - The net profit after deducting non-recurring gains and losses was ¥30,516,105.29, a decline of 49.84% from ¥60,841,741.46 in 2019[15]. - The net cash flow from operating activities was ¥58,299,970.87, a decrease of 35.82% compared to ¥90,842,097.45 in 2019[15]. - The total assets at the end of 2020 were ¥740,999,805.53, an increase of 77.43% from ¥417,625,287.30 at the end of 2019[15]. - The net assets attributable to shareholders at the end of 2020 were ¥697,199,137.66, up 88.50% from ¥369,859,766.45 at the end of 2019[15]. - The basic earnings per share for 2020 were ¥0.40, down 54.55% from ¥0.88 in 2019[15]. - The weighted average return on equity for 2020 was 6.77%, a decrease of 12.71% from 19.48% in 2019[15]. - The company achieved a revenue of RMB 259.56 million in 2020, a decrease of 24.30% compared to the previous year[63]. - The net profit attributable to shareholders was RMB 34.49 million, down 47.46% from RMB 65.64 million in 2019[65]. - The company's gross margin for 2020 was 35.59%, which increased to 38.10% after adjusting for certain costs, reflecting a year-on-year increase of 0.93%[64]. Risks and Challenges - The company acknowledges various risks including fluctuations in gross profit margin, high customer concentration, and rising human resource costs[5]. - The company emphasizes the importance of understanding the differences between plans, forecasts, and commitments in its strategic outlook[5]. - The profit levels in the cosmetic plastic packaging industry are influenced by raw material prices, innovation capabilities, production technology, and product iteration speed[35]. - High-end cosmetic brands tend to invest more in packaging materials, resulting in higher profit margins for suppliers compared to those serving low-end brands[36]. - Fluctuations in upstream plastic prices significantly impact production costs, but companies have managed to control profit levels through efficiency improvements and price adjustments[37]. - The company faces risks from rising labor costs due to economic development in central and western regions, necessitating higher wages to attract workers[120]. - The company is exposed to exchange rate fluctuations, with a significant portion of sales settled in USD, which could impact financial performance[123]. - The company’s export revenue to the U.S. represented 30.20%, 35.71%, and 38.85% of total revenue over the past three years, making it vulnerable to U.S.-China trade tensions[124]. Research and Development - The company holds 56 patents, showcasing its strong research and development capabilities in precision cosmetic plastic bottle molds[53]. - The company has implemented automation in injection molding processes, enhancing production efficiency and reducing labor costs[54]. - The company has achieved significant advancements in mold temperature control technology, improving product quality and reducing defects during the injection molding process[53]. - The company has established a complete injection molding technology system, enabling it to provide comprehensive solutions from precision mold design to injection part formation[55]. - The company is committed to increasing R&D investment to mitigate risks associated with raw material price volatility and maintain competitive advantages[118]. - The company aims to develop new cosmetic products and extend its product line from skincare to color cosmetics, supported by advanced injection molding technology[117]. - R&D investment for the reporting period amounted to ¥11,115,147.19, accounting for 4.28% of operating revenue[79]. - The number of R&D personnel decreased to 85, representing 10.10% of total employees, compared to 10.80% in 2019[79]. Market Position and Strategy - The company has established a strong customer base with leading cosmetic brands such as Estée Lauder and L'Oréal, enhancing its market position[63]. - The company is well-positioned in the overseas market due to its competitive advantages in raw materials and geographical location, despite facing design competition from international players[50]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[136]. - The company is actively participating in domestic and international exhibitions to enhance brand visibility and expand its marketing reach[116]. - The company plans to expand its marketing network by enhancing the sales team and improving sales incentives, aiming for simultaneous growth in domestic and international sales[115]. Compliance and Governance - The financial report is guaranteed to be true, accurate, and complete by the company's management team[4]. - The company has appointed an accounting firm for its financial audits, ensuring compliance and transparency[14]. - The company is under the supervision of regulatory authorities to ensure compliance with securities laws and regulations[140]. - The company’s commitment to transparency and accountability is emphasized through its various promises regarding the IPO process and share buyback measures[141]. - The company has established internal control systems to ensure the proper and efficient use of raised funds, with funds stored in designated accounts for specific purposes[148]. Shareholder Structure and IPO - The company completed its initial public offering (IPO) with 25 million shares issued at a price of RMB 13.99 per share, raising a total of RMB 349.75 million[190]. - Post-IPO, the total share capital increased from 75 million shares to 100 million shares, reflecting a significant change in the shareholder structure[191]. - Major shareholders include Ruan Rongtao with 20.32% (20,324,644 shares) and Shanghai Liyi Equity Investment Center with 18.75% (18,750,000 shares)[193]. - The company has a total of 11,976 shareholders at the end of the reporting period, an increase from 11,176 at the previous month-end[193]. - The company’s equity structure includes a significant portion of shares held under lock-up conditions, indicating a controlled release of shares into the market[188]. - The largest shareholder, Ruan Rongtao, directly holds 20.32% of the company's shares, while he and his wife, Gao Lijun, collectively control 35.11% of the shares[194]. - The company has not conducted any repurchase transactions among the top ten shareholders during the reporting period[195]. - The controlling shareholders, Ruan Rongtao and Gao Lijun, have not changed during the reporting period[196]. Operational Efficiency and Future Plans - The company aims to enhance its competitiveness by integrating precision injection molding, hot stamping, and assembly processes, while reducing manufacturing cycles and costs[111]. - The company plans to launch a new production facility for cosmetic packaging containers with an annual capacity of 45 million sets, expected to commence production in June 2021[67]. - The company is committed to sustainability, with plans to reduce carbon emissions by 20% over the next five years through innovative production processes[137]. - The company plans to implement stock price stabilization measures when the closing price remains below the audited net asset value per share from the previous fiscal year[138]. - The company will consider profit distribution or capital reserve conversion to increase share capital as a primary method for stabilizing stock prices[138].